You are here

Does combination therapy with desmopressin and tolterodine improve the treatment outcomes of patients with monosymptomatic nocturnal enuresis? A randomized clinical controlled trial

F. Kazemi Rashed, D. Nourizade, S. Hajebrahimi, K. Hasanzade, A. Otoofat.

ISRN Urol 2013;2013:413146

Editor's comments

Desmopressin combined with tolterodine improves the treatment outcome in nocturnal enuresisThis study adds to the fact that combination therapy (anticholinergic + desmopressin) improves the outcome compared to demospressin alone

Made possible by an
educational grant
from Ferring


 Subscribe to our E-Alert to stay informed of all new content.


World Bedwetting Day

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.
The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.

Consensus Guidelines

Practical consensus guidelines for the management of enuresis. 
Evaluation and management of enuresis, a common condition, is not a priority in training programs for medical doctors (MDs), despite being a common condition. 

Download the CMT

Diagnosis and Treatment of Nocturnal Enuresis developed by the Working Group of Nocturnal Enuresis Belgium.